The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews.

Machine translation Machine translation
作者
类别 Broad synthesis / Overview of systematic reviews
期刊Respiratory medicine
Year 2006
吸入糖皮质激素形成大多数哮喘患者治疗的基石。甲范围的化合物提供广泛的prescribable剂量。在本文中,我们总结了一些Cochrane系统评价,研究了不同剂量的丙酸倍氯米松,布地奈德和丙酸氟替卡松的相对利益时,用于治疗儿童和成人的调查结果。调查的主要结果是吸入糖皮质激素疗效的措施表现出剂量 - 反应关系,但大多数轻度至中度疾病的好处是获得了在低到中等剂量范围内的每种药物。在这一组中,高剂量的氟替卡松导致小的改进口服副作用的发生率急剧增加的费用控制措施。严重的疾病,是依赖于口服类固醇的患者在减少口服类固醇相比,高剂量的氟替卡松从非常高的,也有可能是可观的利益。
Epistemonikos ID: 6279471a0a1544380825aa09e71e03ada2f6797e
First added on: Nov 28, 2012
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use